Accessibility Statement

Last Updated: 2 April 2026 • Last Reviewed: 2 April 2026

Our Commitment

RxSure is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.

This website partially conforms to the Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA, with the exceptions listed in the Known Limitations section below. These guidelines explain how to make web content more accessible for people with disabilities and more user-friendly for everyone.

Digital Technology Assessment Criteria (DTAC)

RxSure is aligned with the NHS Digital Technology Assessment Criteria (DTAC), which covers five key areas: clinical safety, data protection, technical security, interoperability, and usability and accessibility. Our WCAG 2.1 Level AA conformance contributes to meeting the usability and accessibility requirements of DTAC.

NHS Accessible Information Standard

We have read and considered the NHS Accessible Information Standard. We are committed to ensuring that people who have a disability, impairment, or sensory loss receive information they can access and understand, and that they receive appropriate support to help them communicate effectively with our platform and services.

Accessibility Roadmap

We plan to achieve WCAG 2.2 Level AA conformance by Q4 2026. This includes addressing all known limitations listed below and implementing the updated WCAG 2.2 success criteria across the public website and clinical portals.

Measures We Take

We take the following measures to ensure accessibility:

  • Include accessibility as part of our design and development process
  • Use semantic HTML structure for better screen reader compatibility
  • Provide sufficient colour contrast throughout the website
  • Ensure keyboard navigation is available for all interactive elements
  • Include alternative text for images
  • Use clear and consistent navigation
  • Design forms with clear labels and error messages
  • Regularly test our website for accessibility issues

Accessibility Features

Our website includes the following accessibility features:

Navigation

  • Consistent navigation structure across all pages
  • Skip to main content link (for keyboard users)
  • Logical heading hierarchy
  • Descriptive link text

Visual Design

  • Sufficient colour contrast ratios
  • Resizable text without loss of content or functionality
  • Content is readable without stylesheets
  • No content that flashes more than three times per second

Forms and Interactive Elements

  • Clear form labels and instructions
  • Error identification and suggestions
  • Keyboard accessible controls
  • Focus indicators for interactive elements

Testing Methodology

This accessibility statement was prepared on 30 March 2026 and last reviewed on 2 April 2026. The website was tested using the following tools and methods:

  • Google Lighthouse — automated accessibility scoring (Chrome DevTools)
  • axe DevTools — detailed WCAG 2.1 violation detection (Deque Systems)
  • WAVE — visual accessibility evaluation (WebAIM)
  • Manual keyboard testing — tab order, focus management, skip links
  • Screen reader testing — VoiceOver (macOS), NVDA (Windows)
  • Colour contrast analysis — WebAIM Contrast Checker against WCAG AA (4.5:1 minimum)

Testing was conducted across the public-facing website (rxsure.co.uk). Clinical portals are assessed separately.

Known Limitations

While the majority of this website conforms to WCAG 2.1 Level AA, the following specific non-conformances have been identified:

  • WCAG 1.1.1 (Non-text Content): Some older PDF documents may lack proper text alternatives. Remediation target: Q3 2026 — all PDFs to be updated with accessible alternatives.
  • WCAG 1.3.1 (Info and Relationships): Some third-party embedded content (e.g., Google Maps, booking widgets) may not fully convey structural information to assistive technologies. Remediation target: Q3 2026 — alternative text descriptions and ARIA labels to be added.
  • WCAG 4.1.2 (Name, Role, Value): Some complex interactive components (e.g., cookie consent banner, dynamic pricing toggles) may not fully expose their state to screen readers. Remediation target: Q4 2026 — to be addressed as part of WCAG 2.2 upgrade.

We are committed to resolving these issues and continuously improving the accessibility of our content.

Compatibility

Our website is designed to be compatible with:

  • Recent versions of major browsers (Chrome, Firefox, Safari, Edge)
  • Screen readers including JAWS, NVDA, and VoiceOver
  • Operating system accessibility features
  • Mobile devices and tablets

Technical Specifications

Accessibility of our website relies on the following technologies:

  • HTML5
  • CSS3
  • JavaScript
  • WAI-ARIA

These technologies are relied upon for conformance with the accessibility standards used.

Feedback

We welcome your feedback on the accessibility of our website. Please let us know if you encounter accessibility barriers:

We try to respond to accessibility feedback within 5 business days.

Enforcement Procedure

If you are not satisfied with our response to your accessibility concern, you can contact the Equality Advisory Support Service (EASS):

Website: equalityadvisoryservice.com

The EASS is an independent service that provides advice and assistance on equality and human rights issues.